Regeneron Pharmaceuticals, Inc.
2022 Q1 - 2025 Q4 (16 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 785 | 0.0% | 1,017 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 1,635 | 0.0% | 2,907 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 12,008 | 0.1% | 22,872 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 70,401 | 0.7% | 111,002 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 65,057 | 0.6% | 91,330 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 116,577 | 1.1% | 110,895 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 105,343 | 1.1% | 100,228 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 99,973 | 1.0% | 103,869 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 81,692 | 0.8% | 93,012 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 76,269 | 0.9% | 92,676 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 47,832 | 0.6% | 66,568 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 20,491 | 0.3% | 24,938 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 16,515 | 0.2% | 22,890 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 15,727 | 0.2% | 22,830 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 13,447 | 0.2% | 22,748 | 6/30/2022 |
| 2022 Q1 | 5/19/2022 | 15,918 | 0.2% | 22,792 | 3/31/2022 |